Skip to search formSkip to main contentSkip to account menu

olmesartan

Known as: 4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid, omesartan, 4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid 
A synthetic imidazole derivative and angiotensin II receptor antagonist with antihypertensive activity. Olmesartan selectively binds to the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Olmesartan Medoxomil (OLM) is an angiotensin II receptor blocker antihypertensive agent. It is a highly lipophilic (log p… 
Highly Cited
2010
Highly Cited
2010
From the Department of Cardiovascular Research Medicine,* Nagoya University School of Medicine, Nagoya, Japan; the Department of… 
2009
2009
Comment on: Rhodes DR, et al. Proc Natl Acad Sci USA 2009; 106:10284-9. 
2007
2007
The effect of olmesartan, an inverse angiotensin II type 1 receptor blocker (ARB), on oxidative stress in hemodialysis (HD… 
Highly Cited
2005
Highly Cited
2005
Objective Angiotensin II type 1 receptor blockers (ARB) are widely recognized to have a vasculoprotective effect. Accumulating… 
Highly Cited
2001
Highly Cited
2001
The object of this study is to evaluate the long-term effects of olmesartan on hypertension and the renin-angiotensin-aldosterone…